23 24 the breast tissue microbiome and OdDHL is documented to have significant effects on 36 mammalian cells. We found differences in the MDA-MB-231 and MCF-DCIS.com viability 37 after OdDHL treatment that were cell type and culture condition (i.e. microenvironment) 38 dependent. This result was in contrast to the MCF-10A cells, which demonstrated no change in 39 viability over the OdDHL concentration range examined, in any culture condition. We further 40 determined that the observed trends in breast cancer viability were due to modulation of 41 proliferation for both cell types, as well as the induction of necrosis for MDA-MB-231 cells in 42 all conditions. Our results provide evidence that bacterial quorum-sensing molecules interact 43 with the host environment to modulate breast cancer viability and proliferation, and that the 44 effect of OdDHL is dependent on both cell type as well as microenvironment. Understanding the 45 interactions between bacterial signaling molecules and the host tissue environment will allow for 46 3 future studies that determine the contribution of bacteria to the onset, progression, and therapy 47 response of breast cancer. 48 49 Introduction The tumor microenvironment is now a widely recognized and well-studied 50 contributor to cancer dynamics, particularly for breast cancer. While increased matrix density, 51 programming of cancer-associated stromal cells, evolving gradients of oxygen and nutrients, and 52 leaky vasculature have all been implicated as key players in breast cancer progression (1-4), the 53 impact of the recently identified breast tissue resident microbiotic niche has received little 54 attention. Beyond the effects of pathogenic or tumorigenic bacteria such as Chlamydophila 55 pneumonia, Salmonella typhi, Streptococcus gallolyticus (5), Helicobacter pylori (6) and 56 Fusobacterium nucleatum (7), the majority of analyses of tumor-microbiome interactions have 57 centered on local cell-cell interactions within the gut microenvironment, or more systemic 58 immune effects influenced by gut microbiota (8). Only a handful of studies have been conducted 59 to investigate the influences of tissue-resident bacteria in other tumor sites, such as for breast 60 cancer (9-11). Even fewer have investigated how small molecules released from resident bacteria 61 may interact with cells in the presence of other critical microenvironmental factors, e.g. tumor 62 hypoxia, to regulate cancer progression. In an effort to address these questions, we investigated 63 interactions between the quorum-sensing molecule N-(3-oxododecanoyl)-L-homoserine lactone 64 (OdDHL) and the breast tumor relevant microenvironmental cues of a stiff collagen-derived 65 tissue mimic and hypoxia. This representative study will aid in our understanding of how the 66 understudied breast tissue microbiome may contribute to disease phenotypes, patient-to-patient 67 variability, and cancer progression. 68 69 131 For 2D experimental conditions, cells were seeded in 48-well polystyrene plates at a 132 concentration of 100,000 cells per milliliter (30,000 cells per well), with two plates seeded per 133 cell type per experiment. After seeding, all plates were incubated under standard culture 134 conditions in normoxia. After 24 hours, the media was changed in all wells and the plates that 135 were to undergo the hypoxia treatment were moved into an incubator with 1% oxygen and the 136 standard culture conditions of 37°C, 5% CO 2 . 137 138 157 incubated for 30 minutes at 37°C, then transferred into 24-well plates and covered with 0.6 mL 158 complete media standard of the included cell type. There was one plate of 3D samples per cell 159 type. All 3D samples were maintained in an incubator under standard culture conditions (37°C,
Abstract It is well documented that the tumor microenvironment profoundly impacts the 25 etiology and progression of cancer, and the contribution of the resident microbiome within breast 26 tissue remains poorly understood. Tumor microenvironmental conditions such as hypoxia and 27 dense tumor stroma predispose progressive phenotypes and therapy resistance, yet the role of 28 bacteria in this interplay remains uncharacterized. We hypothesized that the effect of individual 29 bacterial secreted molecules on breast cancer viability and proliferation would be modulated by 30 these tumor-relevant stressors differentially for cells at varying stages of progression. To test 31 this, we incubated human breast adenocarcinoma cells (MDA-MB-231, MCF-DCIS.com) and 32 non-malignant breast epithelial cells (MCF-10A) with N-(3-oxododecanoyl)-L-homoserine 33 lactone (OdDHL), a quorum-sensing molecule from Pseudomonas aeruginosa that regulates 34 bacterial stress responses. Pseudomonas was recently characterized as a significant fraction of 35
OdDHL secreting Pseudomonas are Gram-negative Proteobacteria that were recently found to 70 make up a significant fraction of the microbiome within breast tissue (12), and on nipple skin 71 and aspirate from women with and without a history of breast cancer (13). In addition, 72
Pseudomonas has been shown to make up a significant portion of the bacteria found in human 73 breast milk (11, (14) (15) (16) . Pseudomonas was among the top five most abundant genera for both 74 sample populations in the 2014 study by Urbaniak et al. (12) and in several studies of breast milk 75 microbiota (14) . OdDHL is a quorum-sensing molecule associated with biofilm development and 76 environmental stress response in bacteria (17) that has been shown to promote apoptosis in a 77 variety of human cell lines (18-23). Especially interesting is its selective effect inhibiting 78 proliferation and inducing apoptosis in breast cancer cells, but not in non-malignant breast cells 79 (21) . For these reasons, studying the effects of OdDHL is not only important from the basic 80 science perspective (e.g. regarding its role in the tumor microenvironment), but also from the 81 therapeutic perspective given its potential as an anti-cancer treatment (24, 25) . 82 83 High tissue density is not only a risk factor for breast cancer development, but also a clinical 84 diagnostic tool (26). Increased stroma density (resulting from increased collagen deposition and 85 cross-linking in the extracellular matrix (ECM)) is also associated with phenotypic changes in 86 both cancer cells and normal stroma cells (27) . In an in vitro setting, growing cells on or within a 87 collagen hydrogel, as opposed to on a polystyrene substrate in two-dimensions (2D), changes not 88 only the type of focal adhesions cells make with their environment (28), but also how cells 89 respond to stresses within that environment (e.g. chemotherapeutic agents) (27, 29, 30) . Three-90 dimensional (3D) cellular adhesions are implicated in reduced cellular response to phenotype (27, 31, 32) . Hypoxia is also a well-documented constituent of the solid tumor 93 microenvironment; angiogenesis cannot keep up with the rate of tumor growth and produces a 94 gradient of oxygen from the well-fed periphery to a necrotic core that is devoid of oxygen (33). 95
Similar to cancer cells in a 3D environment, a low oxygen environment is associated with a 96 progressive phenotype and a resistance to chemotherapy (33, 34). Although, adhesion-and 97 hypoxia-mediated resistance have been extensively demonstrated for chemotherapeutic 98 compounds, adhesion-and hypoxia-mediated regulation of cellular response to bacterial 99 signaling molecules has not yet been investigated. Despite the previous research into OdDHL, 100 the role of OdDHL in the context of breast tumor microenvironmental stressors was still 101
unknown. Because such stressors are associated with altered cell responses (e.g. 102 chemoresistance), it was our hypothesis that OdDHL would differentially modulate breast cancer 103 cell viability and proliferation in hypoxia and in 3D culture (in which cells are seeded in the bulk 104 of a tissue mimic). 105
106
In an effort to make a preliminary characterization of the response for both metastatic and non-107 metastatic subtypes of breast cancer, we utilized MDA-MB-231 and MCF-DCIS.com cells, 108 respectively. MCF-10A breast epithelial cells were used as a non-malignant control. Both MDA-109 MB-231 and MCF-10A cells were chosen for this research because of their wide documentation 110 in the literature (35, 36 10A and MCF-DCIS.com cells were cultured in DMEM/F12 (1:1) media supplemented with 5% 125 horse serum, 1% PS, 0.05% hydrocortisone, 0.1% human insulin, 0.02% epidermal growth 126 factor, and 0.01% cholera toxin. Hereafter, these supplemented DMEM/F12 (1:1) media will be 127 referred to as complete media. Cells were subcultured every 4-5 days and used until passage 50. 128
Stock cells were grown in T-75 flasks under standard culture conditions (37°C incubator with 129 5% CO 2 , and ambient O 2 (referred to hereafter as normoxia). 130 7 3D culture. 3D culture was defined as cells suspended throughout a tissue mimic, namely a rat 139 tail derived type I collagen hydrogel. The collagen stock was manufactured using a technique 140 described previously (41). Briefly, collagen was extracted from Sprague-Dawley rat tails 141 (Bioreclamation, Inc), sterilized in 70% ethanol, and dissolved in 0.1% glacial acetic acid for 142 three days. The dissolved collagen stock was then aliquoted, frozen, lyophilized, and stored at -143 20°C. At least three days prior to use, the lyophilized collagen was reconstituted in 0.1% glacial 144 acetic acid at a concentration of 12 milligrams of collagen per milliliter of acetic acid solution, 145 and this dissolved stock solution was then used for up to four weeks post re-constitution. 146
147
The hydrogel was created by neutralizing the collagen stock with empirically derived proportions 148 of 10X DMEM, 1X DMEM/F12 (1:1) and 1M sodium hydroxide (NaOH) (revised from (41)) to 149 create a hydrogel with pH 7.4 and 6 mg/mL of collagen in 0.1% acetic acid solution. During the 150 neutralization process, all solutions were kept on ice to prevent collagen polymerization. Cells 151 were suspended throughout the hydrogel by resuspension of a cell pellet into the required 1X 152 DMEM/F12 (1:1) prior to its addition into the unpolymerized (but neutralized) hydrogel 153 solution. Cells were seeded in the hydrogel solution at a concentration of three million cells per 154 milliliter of solution (~300,000 cells per well). The hydrogel solution was pipetted into 155 pretreated SYLGARD® 184 silicone elastomer molds topped with untreated coverslips to create 156 approximately 1 mm thick discs comprised of ~0.1 mL hydrogel solution. The hydrogels were 5% CO 2 , normoxia). Hydrogels with no cells were also created as a control for the alamarBlue™ 161 cell viability assay described below. where there were no cells. These were incubated in normoxic or hypoxic incubators until positive control wells (0.6% DMSO control) were magenta in color; reduction rate was 184 dependent on cell type and culture condition. When controls wells showed the color change, 185 three subsamples were taken from the solution of each well and added to a 96-well plate. As per 186 the manufacturer's instructions, the 96-well plates were read on a spectrophotometer, which 187 analyzed the absorbance at 570 and 600 nm wavelengths. The percent reduction of alamarBlue™ 188 was calculated with the equation recommended by the manufacturer, namely: 189
where O 1 is the molar extinction coefficient (E) of oxidized alamarBlue™ at 570 nm, O 2 is the E 190 of oxidized alamarBlue™ at 600 nm, R 1 is the E of reduced alamarBlue™ at 570 nm, R 2 is the E 191 of reduced alamarBlue™ at 570 nm, A 1 is the absorbance of the test well at 570 nm, A 2 is the 192 absorbance of the test well at 600 nm, N 1 is the absorbance of the negative control at 570 nm and 193 contrasts were performed to analyze the degree of significance between experimental conditions. 236
Error bars represent standard error of the mean. 237
238
Results It was found that the response to OdDHL was dependent not only on cell-type, but also 239 the culture condition. As compared to the control, the malignant MDA-MB-231 cells showed 240 significantly different responses to 400 µM of OdDHL in all culture conditions (Fig 1A-1E) . In 241 the 2D/normoxia condition, the 400 µM OdDHL treatment corresponded to approximately 242 52.2% (± 2.2%) viability, relative to the control. In the 2D/hypoxia condition, that relative 243 viability was increased to 60.6% (± 2.2%) and in 3D/normoxia condition, that viability was 244 increased to 81.9% (± 2.2%) ( Fig 1C and Fig 1D, respectively) . There were significant decreases 245 in the MDA-MB-231 viability at the 100 and 200 µM levels of OdDHL, as compared to the 246 control, for the 2D conditions as well ( Fig 1A and Fig 1B) . In contrast, the non-malignant MCF-247 10A cells exposed to OdDHL showed no significant change in viability relative to the control 248 across all concentrations in all culture conditions (Fig 1F-1H) . 249 The viability assay of the MCF-DCIS.com cells showed the cells responded in a similar fashion 267 to MDA-MB-231 cells in both the 2D/normoxia and 2D/hypoxia conditions, with significant 268 dose-dependent decreases in viability with increasing OdDHL concentrations (Fig 2A) . 269
However, unlike the MDA-MB-231 cells, the MCF-DCIS.com cells did not have a significant 270 decrease in viability in the 3D/normoxia condition at any treatment level of OdDHL ( Fig 2B) . 271
Also, unique to the MCF-DCIS.com cells is a significantly lower viability at the 400 µ M level 272 for MCF-DCIS.com cells cultured in 2D/hypoxia than those cultured in 2D/normoxia ( Fig 2C) . 273
However, for MCF-DCIS.com cells grown in 3D versus 2D in normoxia, there was significantly 274 increased MCF-DCIS.com viability with the 400 µ M OdDHL treatment ( Fig 2D) . An analysis of 275 the cell specific viability response to 400 µ M OdDHL showed that MCF-DCIS.com cells have 276 significantly higher viability than MDA-MB-231 cells, but significantly lower viability than 277 MCF-10A cells when cultured under the 2D/normoxia condition (Fig 2E) . With the same 278 treatment, MCF-DCIS.com cells showed significantly lower viability than MCF-10A cells when 279 cultured under the 2D/hypoxia (a response that is statistically not different from that of MDA-280 MB-231 cells under the same condition) ( Fig 2E) . When cells were cultured under the 281 3D/normoxia condition, there was no difference in MCF-DCIS.com viability as compared to 282 MCF-10A cell viability with the 400 µ M OdDHL treatment; both were significantly higher than 283 MDA-MB-231 cell viability under the same condition ( Fig 2F) . OdDHL-treated MDA-MB-231 cells than for control (0.6% DMSO) cells across all culture 301 conditions ( Fig 3A, Fig 3B) . The comparison of MDA-MB-231 proliferation between the 302 different culture conditions can more readily be seen in Fig 3C and Fig 3D. The percentage of 303
EdU-tagged cells after the two hour incubation period was also lower for 400 µM OdDHL-304 treated versus the control cells across all culture conditions for the MCF-DCIS.com cells. The 305 comparison of MCF-DCIS.com proliferation between the different culture conditions can more 306 readily be seen in Fig 3G and Fig 3H. significantly increased ( Fig 4A) . Analysis of the MGV for the PI staining showed significantly 326 increased necrosis of MDA-MB-231 with 400 µ M OdDHL treatment, relative to the 0.6% 327 DMSO control, in all culture conditions ( Fig 4B) . Analysis of MGV for the AV-FITC and PI 328 staining of MCF-DCIS.com cells showed significantly increased apoptosis and necrosis, 329 respectively, only for cells in 2D/normoxia with the 400 µ M OdDHL treatment ( Fig 4C and Fig  330   4D ). The PI staining of the MCF-DCIS.com cells in the 3D/normoxia showed that these cells had 331 decreased necrosis with 400 µ M OdDHL treatment, relative to the control ( Fig 4D) . The 400 µ M 332
OdDHL did not significantly increase apoptosis or necrosis of MCF-10A cells compared to the 333 0.6% DMSO control ( Fig 4E and Fig 4F) . Rather, 400 µ M OdDHL significantly decreased both 334 MCF-10A apoptosis and necrosis under the 3D/normoxia condition compared to the 0.6% 335 DMSO control ( Fig 4E and Fig 4F) . 336 changes. As we anticipated, cells cultured in a 3D environment had the highest relative viability 362 ( Fig 1) with OdDHL treatment as compared to cells in 2D. Cells in hypoxia also had increased 363 relative viability with OdDHL treatment as compared to those in normoxia (Fig 1) . Thus, we 364 found that OdDHL preferentially affects MDA-MB-231 cells as compared to MCF-10A cells 365 and this effect is blunted by both hypoxia and 3D culture. 366
367
It is interesting to note that, while MDA-MB-231 cells had a decreased viability response when 368 cultured under hypoxia and 3D conditions, the MCF-DCIS.com cells did not respond in the same 369 way (Fig 2) . MCF-DCIS.com viability was in-between that of the MCF-10A and MDA-MB-231 370 cells in 2D/normoxia, statistically similar to the MDA-MB-231 response in 2D/hypoxia, and 371 statistically similar to the MCF-10A response in 3D/normoxia (Fig 2) . This novel evidence 372 suggests that bacterial factors may affect mammalian cells differently at each stage of cancer 373 progression. It is possible that the response to OdDHL is linked to epithelial-to-mesenchymal 374 transition as it has previously been shown that OdDHL has an effect on cytoskeletal proteins in 375 multiple malignant cell lines (24, 43) . OdDHL may be differentially affecting the MDA-MB-231 376 cells in comparison to the MCF-DCIS.com cells due to its mesenchymal and highly metastatic 377 characteristics; however, much more work needs to be done for confirmation of this hypothesis. 378
379
In order to better understand the decreases in viability for the breast cancer cells as measured by 380 the alamarBlue™ assay, we decided to examine the effect of OdDHL on both cell proliferation 381 and apoptosis/necrosis. For MDA-MB-231 cells, it was revealed that OdDHL has two 382 mechanisms to decrease the cell number. We found that OdDHL significantly decreases 383 proliferation of MDA-MB-231 cells in all culture conditions (Fig 3) . We then hypothesized that 384 decrease in proliferation alone could not account for the decrease in viability we observed. A 385 second mechanism of action was found in the apoptosis/necrosis assay. We found that necrosis 386 of MDA-MB-231 cells was significantly increased with the 400 µ M OdDHL treatment as 387 compared to the 0.6% DMSO control (Fig 4) . 388
389
This effect was not seen in MCF-10A cells and, in fact, was reversed for MCF-10A cells 390 cultured in the 3D/normoxia condition (Fig 4) . The fact that OdDHL triggers necrosis as opposed 391 to apoptosis is not surprising; bacteria are known to induce necrosis (44). However, the fact that 392
OdDHL may reduce apoptosis and necrosis for non-malignant cells under a stressful 393 microenvironment (i.e. a stiff collagen matrix) is intriguing. More research is needed to 394 understand the selectivity of necrosis induction and, especially, reduction by OdDHL. 395 396 Likewise, we found that the primary mechanism responsible for the decrease in MCF-DCIS.com 397 cell number seen with OdDHL treatment was decreased proliferation (Fig 3) . The decreased 398 proliferation was observed in all three culture conditions, which seemed to conflict with the lack 399 of decreased viability seen for MCF-DCIS.com cells in the 3D/normoxia condition. The 400 apoptosis/necrosis assay shed some light on this seemingly contradictory result. It was found 401 that, as with the MCF-10A cells, there was decreased necrosis for MCF-DCIS.com cells in the 402 3D/normoxia condition (Fig 4) . From these data, it seems that the opposing effects of the 403 decreased proliferation and the decreased necrosis caused by the 400 µ M OdDHL treatment 404 countered each other, leading to the invariable response in viability observed. Like the MDA-405 MB-231 cells, the MCF-DCIS.com cells in the 2D/normoxia condition also exhibited increased 406 necrosis; however, these cells also had increased apoptosis (Fig 4) . Taken together, these data are 407 indicative that there may be different mechanisms of OdDHL action on cancer viability and these 408 are cell type and microenvironmental condition dependent. While more work with cells 409 representative of varying stages of progression needs to be completed, these preliminary data 410 suggest that OdDHL may be more effective at suppressing the growth of more malignant or 411 advanced breast cancer. is not yet known whether these microbiome compositions are a cause or consequence of the 440 malignancies (9). Our data provide an important contribution to this field, demonstrating that 441 even for one quorum-sensing molecule there is a complex breast cell response that is dependent 442 on both cell type as well as microenvironmental context. Many more studies of breast relevant 443 bacteria secreted molecules are needed to establish the impact of the soluble factor crosstalk 444 between the microbiome and breast cancer during the entire course of progression as well as 445 during therapy response. With our data, we have established the importance of performing these 446 investigations in the context of physiologically relevant in vitro models. Thus, such 447 investigations would benefit from the incorporation of microenvironmental stressors. More 448 broadly, co-culture experiments investigating soluble factor interactions between breast tissue 449 relevant bacteria and cancer cells in the context of tumor microenvironmental stressors could 450 provide valuable insights into carcinogenesis as well as patient-to-patient variability in disease 451 course and therapy response. 452
